banner
Inquiry

Cat. No.: X24-09-YM916

ISX-9, Purity ≥98%

Synonym: 832115-62-5; Isoxazole 9; ISX 9; ISX9; N-Cyclopropyl-5-thiophen-2-yl-1,2-oxazole-3-carboxamide

  • MDL: MFCD04133937
  • CAS Number: 832115-62-5
  • Compound CID: 19582717
img
Product Size
10 mg; 25 mg; 50 mg; 100 mg
Price
Datasheet
MSDS
Properties
Description
ISX-9, soluble in DMSO and ethanol and insoluble in water, is a small molecule inducer of adult neural stem cell differentiation. The molecular weight of the compound is 234.27, and its molecular formula is C11H10N2O2S.
Molecular Weight
234.27
Molecular Formula
C11H10N2O2S
Form
Lyophilized powder
Purity
≥98%
Impurities
Free from inappropriate visible particulates, foreign matter, discoloration, or other defects.
Solubility
In vitro: DMSO: 44 mg/mL (187.81 mM); Water: insoluble; Ethanol (warmed): 12 mg/mL (51.22 mM); In vivo: 5% DMSO + 55% PEG 300 + ddH2O, 9 mg/mL
Identity
Confirmed by NMR/HPLC/MS.
Applications
ISX-9 can be studied extensively for its potential therapeutic applications in the treatment of obesity and related metabolic conditions.
Publications
Publications (0)

Publications

×
Publications

Thank you for choosing our products for your research. By sharing your publications or experimental feedback, you provide invaluable insights that help fellow scientists accelerate their discoveries. Your contribution also drives our commitment to continuous product optimization.

As a token of our appreciation, verified submissions will receive an exclusive discount code for your next order.

*Submitted research data and images may be featured on our product pages. We strictly protect your personal privacy; no sensitive contact information will ever be disclosed.

  • You can upload up to 5 images or ZIP files, and the size of a single file may not exceed 5MB.
Related Products

About Us

CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.

Contact Us

Copyright © CD BioGlyco. All rights reserved.
0